跳至主要内容
临床试验/NL-OMON56590
NL-OMON56590招募中3 期

The beneficial value of 18F FDG PET/CT in the follow-up of stage III non-small cell lung cancer patients - NVALT31-PET Study

Radboud Universitair Medisch Centrum0 个研究点目标入组 690 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
690

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Cytological or histologically proven stage III non-small cell lung cancer
  • before start of curative intent treatment
  • Treated with curative intent and started follow-up care
  • All adjuvant treatments are permitted as co-intervention during follow-up care
  • Age 18 years or older
  • ECOG Performance Status classification 0-2 at moment of inclusion
  • Written and signed informed consent by the patient or their representative
  • (with the understanding that consent may be withdrawn by the patient or their
  • representative at any time without consequences to future medical care)

排除标准

  • Life expectancy shorter than 6 months at the end of curative intent treatment
  • Evidence of recurrence after end of curative intent treatment and before
  • randomization (4 months follow-up)
  • Any condition that, in the opinion of the investigator, would interfere with
  • evaluation of the intervention or interpretation of HRQOL or other study

研究者

相似试验